AKT1 and prostate cancer: We identified 18 statistically significant pathways, including chemical carcinogenesis - receptor activation, prostate cancer, antifolate resistance, PI3K-Akt signaling pathway, and neuroactive ligand-receptor interaction, among others (Figures 2E,F).